Nutraceuticals Market in India 2012

Netscribes (India) Pvt. Ltd.
Published Date » 2012-03-06
No. Of Pages » 83

The healthcare industry in India is showing great progress. There has been considerable increase in spending on healthcare backed by the growing purchasing power of individuals. Moreover, with a lot of importance being given to preventive medication, the nutraceuticals market in India is set to flourish. It is one of the booming markets in India. Predominantly vitamins and minerals derived from oral pills were used for curing certain diseases and ailments. People today are becoming more prone to consume immunity enhancing food supplements and wellness related products. This is promoting the growth of the industry with players diversifying into production of various new varieties of products. Further assistance from the government and increasing demand from consumers will fuel growth in this market.

The report begins with an introduction to the Indian nutraceuticals market and its classification on the basis of the ingredients and benefits incurred from them. This is followed by the market overview section which provides the market size and growth as well as the market share of the various segments in the market, namely, functional foods, dietary supplements and functional beverages. A detailed description of each segment in the market along with the dominant products in the particular category has also been provided. Focusing on one the major sub-segments, an overview of the probiotic market in India has been included. 

This segment has been highlighted owing to the fact that it is one of the most promising categories under the nutraceutical market and has huge growth potential in the near future with growing interests of players. The genesis of probiotics has been highlighted showing the types dominant in India and the key therapeutic benefits derived from them. This section also contains information regarding the market size and growth of probiotics in functional foods in India as well as the key segments and the active players in this space.

This is followed by an analysis of the drivers leading to growth in the market. This includes increasing shift towards preventive therapies, increasing disposable income, increase in healthcare spending, increasing shift towards self-medication, changing demographics, growth in pharmacy and wellness related retail chains and favorable pricing environment. The key challenges to the market include lack of standardization, marketing and distribution challenges, high pricing and lack of awareness. Several trends have also been identified in the market and this has been provided in the next section. The key trends include fortified foods, ayurvedic nutraceuticals, foreign tie-ups, players educating consumers, encapsulation, and cosmeceuticals and nanoceuticals. A section on government regulations in the industry has also been included. It discusses the Food Safety and Standards Act 2006 that regulates the industry.

The competition section provides an overview of the competitive landscape in the industry and includes a detailed profile of the major players in the market. The Porter’s Five Forces analysis for the cath lab market is provided in this section. A summary of the major public players operating in the market has also been provided in the form of a bubble chart. A bubble chart has also been provided for the major private players. It also includes the list of products and services, key people, financial snapshot, key ratios and key recent developments for the major players.

The various financial transactions as well as the key recent development that have taken place in the market have been also been provided in the subsequent sections. A section providing strategic recommendations has been added at the end of the report which gives effective solutions to existing and potential players for improving market share and increasing their profitability.
Table of Contents

Page 1: Executive Summary

Page 2: Definition of Nutraceuticals and their Classifications

Market Overview
Page 3: Nutraceuticals Overview, Market Size and Growth (Value-Wise; 2010 2015e), Market Segmentation (2011)
Page 4: Dietary Supplements Overview and Key Products
Page 5: Functional Foods Overview and Key Products
Page 6: Functional Beverages Overview and Key Products

Probiotic Market
Page 7: Genesis of Probiotics
Page 8: Therapeutic Benefits of Probiotics
Page 9: Probiotics in Functional Foods Overview, Market Size and Growth (Value-Wise; 2010 2015e), Market Segmentation (2011)
Page 10: Major Pharmaceutical Companies Active in the Probiotics Market

Drivers & Challenges
Page 11: Summary
Page 12-17: Drivers
Page 18-20: Challenges

Page 21: Summary
Page 22-27: Key Trends

Government Regulations
Page 28: Genesis of Food Safety and Standards Act, 2006
Page 29: Food Safety and Standards Act, 2006 Objectives, Key Features and Implications

Page 30: Market Competition Porters Five Forces Analysis
Page 31: Major Public Companies Summary
Page 32-58: Major Public Players
Dabur India Ltd.
Dr. Reddy's Laboratories Ltd.
Lupin Ltd.
Piramal Healthcare Ltd.
Ranbaxy Laboratories Ltd.
Wockhardt Ltd.
Abbott India Ltd.
GlaxoSmithKline Consumer Healthcare Ltd.
Pfizer Ltd.
Page 59: Major Private Companies Summary
Page 60-79: Major Private Companies
Avesthagen Ltd.
Guardian Lifecare Pvt. Ltd.
Reliance Wellness Ltd.
The Himalaya Drug Company
USV Ltd.
Amway India Enterprises Pvt. Ltd.
Herbalife International India Pvt. Ltd.

Financial Transactions
Page 80: Financial Transactions in the Last 5 Years

Key Developments
Page 81: Recent Developments

Strategic Recommendations
Page 82: Key recommendations

Page 83: Appendix

List of Tables

Market Overview
1. Dietary Supplements Key Products and Examples
2. Functional Foods Key Products and Examples
3. Functional Beverages Key Products and Examples
Probiotic Market
4. Therapeutic Benefits of Probiotics
5. Major Pharmaceutical Companies Active in the Probiotics Market
6. Foreign Tie-Ups
7. Examples of Players Educating Consumers
8. Company profiles (All companies)
a. Company information
b. Products and services
c. Key people 
d. Key Financial Performance Indicators
e. Key Ratios
f. Key Recent Developments
9. Ratio Calculations

List of Figures

Market Overview
1. Nutraceuticals Market Size & Growth (Value-Wise, 2010 2015e)
2. Nutraceuticals Market Segmentation (2011)
3. Vitamins and Minerals Market Size & Growth (Value-Wise, 2010 2015e)
Probiotic Market
4. Probiotics in Functional Foods Market Size & Growth (Value-Wise, 2010 2015e)
5. Probiotics in Functional Foods Market Segmentation (2011)
Drivers and Challenges
6. Chronic Diseases in India
7. Per Household Annual Income
8. Aggregate Annual Disposable Income
9. Healthcare Spending
10. Composition of Healthcare Spending
11. Population Above 60 Years in India
12. Pharma Retail Growth
13. Major Public Companies Summary (Bubble Chart)
14. Major Private Companies Summary (Bubble Chart)
15. Financial Snapshot (All companies except The Himalaya Drug Company)
16. Key Business Segments (only Public Companies)
17. Key Geographic Segments (only Public Companies)

Upcoming Reports:

Dyslipidemia Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Dyslipidemia is a lipoprotein metabolism disorder characterized by abnormal amount of lipoprotein (LDL and HDL) concentrations in blood. It is usually caused by genetic factors, secondary factors or a combination of both kinds of factors. High density lipoproteins (HDL) are also known as good cholesterol and higher levels of these help reduce the risk of cardiovascular diseases. Higher levels of low density lipoproteins (LDL) or bad cholesterol are associated with the risk of heart attacks and strokes. The abnormal levels of cholesterol and triglycerides are capable of producing three...
Inhalation & Nasal Spray Generic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Generic drugs are drugs that are not associated with any company or a brand name and are subject to regulation of countries where they are dispensed. According to US FDA generic medicines are drugs that are identical or within an acceptable bioequivalent range with respect to pharmacokinetics and pharmacodynamics properties of branded drugs. More than 75% of the respiratory prescription drugs are delivered using inhalation or nasal spray technology. High revenue generator drugs are undoubtedly attracting the interest of generic drug manufacturers due to low cost of manufacturing. Though...
Clinical Nutrition Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Clinical nutrition provides sufficient amount of nutrients such as vitamins, protein and mineral to the patients and also helps to keep energy balance. Clinical nutrition products help to improve digestion, metabolisms, absorption, transportation, storage and discharge from the human body. Infant, enteral and parenteral nutrition are the major segments of clinical nutrition products. Enteral nutritions consumed orally such as nutritional drinks and provide nutrients to the patients who cannot ingest. Parenteral nutrients provided to patients through feeding tube. Infant nutrients...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Select License type:

Share this report

Related News

Top End Stereo Systems Maker Harman Targets Chinese Auto Market
Apr 22, 2014  
Harman, the U.S.-based audio company that is best known as the provider of automobile stereos for top-end car models such as Mercedes-Benz, BMW and Ferrari, has said that it has signed agreements with two leading Chinese automakers—Chang’An and Geely. The company, that is associated with premium infotainment systems for leading auto makers, said that these new contracts...
Scientists Identify Cure for Dengue
Apr 18, 2014  
In a breakthrough discovery that can change the way dengue is treated, scientists have identified a drug target for the deadly dengue viruses. This discovery may help pave the way for discovery of vaccines that can cure this condition that affects nearly 390 million people throughout the world each year.  Scientists have used a new technique for this discovery to show that a region...
India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014  
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015.  Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...